Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
peripheral artery disease
MedTech
R3 Vascular raises $87M for bioresorbable, below-the-knee stent
On the heels of a groundbreaking FDA approval for a major medtech, a Silicon Valley startup is shaping up to be a possible competitor.
Conor Hale
May 17, 2024 12:31pm
FDA approves Abbott dissolving stent for arteries below the knee
Apr 29, 2024 9:54am
J&J adds Shockwave to its cardio collection with $13.1B deal
Apr 5, 2024 11:00am
Cagent nets $30M for serrated balloon catheter
Feb 21, 2024 12:00pm
Abbott's drug-laden, resorbable implant clears leg artery study
Oct 27, 2023 10:38am
AI-powered in-vein ultrasound maker Evident Vascular unveiled
Oct 18, 2023 9:20am
